Furthermore, patients on statin therapy after ischemic stroke have shown lower Lp-PLA2 compared with those without it [107], but pharmaceutical inhibition of Lp-PLA2 has failed to demonstrate a significant association with improved prognosis in patients with stable coronary artery disease or after an acute coronary syndrome [105]. This evidence concerns the gene PLA2G7 and coronary artery disorder.